When we classified the data according to glioma tissue type in the French and TCGA datasets, we found that the expression level of Orai2 in GBMs was also higher than that of astrocytomas, oligoastrocytomas, and oligodendrogliomas. The gene discussed is ORAI2; the disease is central nervous system cancer.